Duct-to-mucosa versus invagination pancreaticojejunostomy after pancreaticoduodenectomy: a meta-analysis

Oncotarget. 2017 Jul 11;8(28):46449-46460. doi: 10.18632/oncotarget.17503.

Abstract

Objective: We aimed to compare the two most commonly used pancreatico-jejunostomy reconstruction techniques-duct-to-mucosa and invagination.

Methods: Databases, including MEDLINE, EMBASE, Cochrane Library, and several clinical trial registration centers were searched. Randomized controlled trials that compared duct-to-mucosa and invagination pancreaticojejunostomy techniques after pancreaticoduodenectomy were included and analyzed.

Results: In total, seven RCTs were included, involving 850 patients. The difference in postoperative pancreatic fistula rate between the duct-to-mucosa and invagination pancreaticojejunostomy was not significant (RR = 1.03, 95% CI = 0.76-1.39, P = 0.86). There was no significant difference in clinically relevant postoperative pancreatic fistula between the two groups (RR = 0.78, 95% CI = 0.15-3.96, P = 0.77). The overall morbidity, overall mortality, delayed gastric emptying, intra-abdominal collection, reoperation rate, and length of hospital stay between the two groups were not significantly different. Sensitivity analysis showed that the meta-analysis was stable. Further, no significant publication bias was seen.

Conclusions: Duct-to-mucosa and invagination pancreaticojejunostomy techniques after pancreaticoduodenectomy were comparable in terms of postoperative pancreatic fistula incidence and other parameters.

Keywords: duct-to-mucosa; invagination; pancreaticoduodenectomy (PD); pancreaticojejunostomy (PJ); postoperative pancreatic fistula (POPF).

Publication types

  • Meta-Analysis

MeSH terms

  • Humans
  • Length of Stay
  • Odds Ratio
  • Pancreatic Diseases / complications*
  • Pancreatic Diseases / surgery
  • Pancreaticoduodenectomy / adverse effects*
  • Pancreaticoduodenectomy / methods
  • Pancreaticojejunostomy* / methods
  • Postoperative Complications / diagnosis*
  • Postoperative Complications / mortality
  • Postoperative Complications / surgery*
  • Publication Bias
  • Survival Rate
  • Treatment Outcome